Kang Liu

机构：Anhui University of Traditional Chinese Medicine, Hospital of Hebei Province, National Epilepsy Center · ORCID：0000-0002-1012-7190

发表论文 82 篇 · 总被引 1044 次 · h-index 18

代表论文

• Mutant p53 variants differentially impact replication initiation and activate cGAS-STING to affect immune checkpoint inhibition (2025 · Communications Biology · 被引 7)
• Oncolytic Hydrogel Enhances Immune Checkpoint Blockade by Generating In Situ Vaccine, Remodeling Tumor Physical and Metabolic Barriers (2025 · ACS Nano · 被引 7)
• Inflammation-targeted nanomedicine prevents tumor metastasis following photodynamic therapy by reversing epithelial-mesenchymal transition and ROS-mediated immunosuppression (2025 · Journal of Nanobiotechnology · 被引 7)
• The influence of electronic AKI alert on prognosis of adult hospitalized patients: a systematic review and meta-analysis (2025 · Critical Care · 被引 6)
• Precisely Controlling the Activation of an Iron-Locked Drug Generator in the Liver Sinusoid to Enhance Barrier Penetration and Reduction of Liver Fibrosis (2024 · Journal of the American Chemical Society · 被引 6)
• CircASH1L inhibits ferroptosis and enhances cisplatin resistance by sponging miR-515-5p to regulate cell cycle-related CDCA7/RRM2 in ovarian cancer cells (2025 · Frontiers in Pharmacology · 被引 5)